Syndax Pharmaceuticals Inc (SNDX)
Operating Income Growth
42.33%
Quarterly · Period ending:
SNDX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported42.33%period ending
Latest reported42.33%period ending
SNDX Quarterly Operating Income YoY % (-283545.32% → 42.33%)
Year-over-year change
High-resolution chart · PNG
SNDX operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 42.3313% | |
| 59.1652% | |
| 35.0926% | |
| 35.892% | |
| 6.5525% | |
| -5.3362% | |
| -23.6955% | |
| -58.9513% | |
| -49.3941% | |
| -72.8002% | |
| -85.3425% | |
| -60.3682% | |
| -31.6881% | |
| -24.844% | |
| -143.8992% | |
| -75.4243% | |
| -68.9084% | |
| -35.6919% | |
| 582.1198% | |
| -0.9016% | |
| -34.4612% | |
| -79.8874% | |
| -39.8099% | |
| -50.9849% | |
| -8.0395% | |
| -1.9513% | |
| 26.5246% | |
| 26.299% | |
| 18.875% | |
| 25.0114% | |
| 0.8005% | |
| -15.5056% | |
| -36.9094% | |
| -49.89% | |
| -74.9304% | |
| -1.365% | |
| -60.3197% | |
| -50.5427% | |
| -138.1064% | |
| -160.1229% | |
| -55.7921% | |
| -97.4064% | |
| -42.2621% | |
| 24.2761% | |
| 12.3656% | |
| -11.3231% | |
| -14.2411% | |
| -238.704% | |
| -201.5737% | |
| -203.8139% | |
| -283,545.3202% |